Skip to main content

VESICULAS EXTRACELULARES DERIVADAS DE ALIMENTOS VEGETALES PARA MEJORAR LA BIODISPONIBILIDAD Y LA BIOACTIVIDAD DE LOS (POLI)FENOLES DIETETICOS Y LOS ARN EXTRACELULARES

PID2022-143100OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Therapeutic potential of plant-derived extracellular vesicles as nanocarriers for exogenous miRNAs

  • López de las Hazas, María-Carmen
  • Tomé-Carneiro, Joao
  • Pozo-Acebo, Lorena del
  • Saz, Andrea del
  • Chapado, Luis A.
  • Balaguer, Livia
  • Rojo, Enrique
  • Espín de Gea, Juan Carlos
  • Crespo, Carmen
  • Moreno, Diego A.
  • García-Viguera, Cristina
  • Ordovás, José M.
  • Visioli, Francesco
  • D´Avalos, Alberto
Cell-to-cell communication strategies include extracellular vesicles (EVs) in plants and animals. The bioactive molecules in a diet rich in vegetables and fruits are associated with disease-preventive effects. Plant-derived EVs (PDEVs) are biogenetically and morphologically comparable to mammalian EVs and transport bioactive molecules, including miRNAs. However, the biological functions of PDEVs are not fully understood, and standard isolation protocols are lacking. Here, PDEVs were isolated from four foods with a combination of ultracentrifugation and size exclusion chromatography, and evaluated as vehicles for enhanced transport of synthetic miRNAs. In addition, the role of food-derived EVs as carriers of dietary (poly)phenols and other secondary metabolites was investigated. EVs from broccoli, pomegranate, apple, and orange were efficiently isolated and characterized. In all four sources, 4 miRNA families were present in tissues and EVs. miRNAs present in broccoli and fruit-derived EVs showed a reduced RNase degradation and were ferried inside exposed cells. EVs transfected with a combination of ath-miR159a, ath-miR162a-3p, ath-miR166b-3p, and ath-miR396b-5p showed toxic effects on human cells, as did natural broccoli EVs alone. PDEVs transport trace amounts of phytochemicals, including flavonoids, anthocyanidins, phenolic acids, or glucosinolates. Thus, PDEVs can act as nanocarriers for functional miRNAs that could be used in RNA-based therapy, This research was funded by MCIN/ AEI /10.13039/501100011033 (PID2019–109369RB-I00), by the European Union NexGenerationEU/PRTR (TED2021–130962B-C21 and TED2021–130962B-C22) and ERDF A way of making Europe (PID2022–143100OB-I00), and by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409). It was also partly funded by the Spanish Foundation of Arteriosclerosis (“Manuel de Oya” Nutrition Grant 2021 to MCLH). MCLH is a recipient of a Juan de la Cierva Grant IJC2020–044353-I/MCIN/AEI/10.13039/501100011033/EU/PRTR. AS-L is supported by a predoctoral fellowship (Nº 2021–01- PhD GRANT) from the International Olive Council. In addition, this research was also partially supported by Fundación Seneca - Murcia Regional Agency for Science and Technology (CARM), Project Reference N# 20855/PI/18. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Anti-steatotic effect of Opuntia ficus-indica extracts rich in betalains and phenolics from fruit peel and pulp of different varieties in in vitro models

  • Besné-Eseverri, Irene
  • Trepiana, Jenifer
  • Eseberri, Itziar
  • Gómez-Maqueo, Andrea
  • Cano, M. Pilar
  • Tomé-Carneiro, Joao
  • Dávalos, Alberto
  • Portillo, María P.
Opuntia ficus-indica exhibits antioxidant, anti-inflammatory and anti-hyperglycemic properties, making it a promising candidate for the prevention and treatment of metabolic dysfunction-associated fatty liver disease. However, its effects on triglyceride accumulation remain largely unexplored. The aim of the present study is to evaluate the anti-steatotic effect of peel and pulp extracts from different varieties of Opuntia ficus-indica fruits (Pelota, Colorada and Sanguinos) in hepatic murine in vitro models, using both AML12 hepatocytes and hepatic organoids. The pulp extracts of Pelota and Colorada varieties, as well as both peel and pulp extracts of Sanguinos, were effective in reducing palmitic acid-induced triglyceride accumulation in AML12 hepatocytes. The doses that caused the greatest triglyceride reduction were 50 µg/mL of the pulp of Pelota and 100 µg/mL for the other extracts. The potential mechanisms underlying these effects seem to be associated, at least in part, with the inhibition of fatty acid uptake and triglyceride assembly. The pulp extract of the Colorada variety was able to prevent triglyceride accumulation also in hepatic organoids, likely due to downregulation of fatty acid transporters. These findings underscore the value of employing diverse in vitro models (e.g., 2D, 3D) to investigate the potential effects of these extracts, and suggest that the pulp extract of the Colorada variety may be effective in preventing steatosis., Irene Besné-Eseverri acknowledges financial support from the FPI Program of the Spanish Ministerio de Ciencia e Innovación (PRE2021-097214). This study was supported by MCIN/AEI /10.13039/501100011033 and “ERDF A way of making Europe” through projects (PID2020-118300RB-C22, PID2020-118300RB-C21 and PID2022-143100OB-I00, co-funded by FEDER). It was also funded by the Instituto de Salud Carlos III (CIBERobn) (CB12/03/30007 and CB22/03/00068), by the Government of the Basque Country (IT1482-22) and by the Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409)., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Milk and cheesemaking whey as a sustainable source of extracellular vesicles: Exploring large-scale isolation methods with industrial and potential therapeutic applications

  • Del Saz-Lara, Andrea
  • López de Las Hazas, María-Carmen
  • Tomé-Carneiro, João
  • Mazarío-Gárgoles, Carmen
  • Gil-Zamorano, Judit
  • Balaguer, Livia
  • Del Pozo-Acebo, Lorena
  • González-Sarrías, Antonio
  • Ávila-Gálvez, María Ángeles
  • Espín de Gea, Juan Carlos
  • Gómez-Coronado, Diego
  • Visioli, Francesco
  • Dávalos, Alberto
Milk extracellular vesicles (EVs) represent promising drug delivery platforms, yet current isolation methods face scalability challenges. Ultracentrifugation (UC), the gold standard, is expensive and energy-intensive, limiting pharmaceutical and pharmacological implementation. This study aimed to standardize scalable EV isolation methods and evaluate cheesemaking whey as a sustainable alternative to milk for therapeutic applications. We systematically compared isolation techniques including UC, tangential flow filtration (TFF), and polyethylene glycol (PEG) co-precipitation across milk and whey from bovine, caprine, and ovine sources. Casein removal strategies using acidification and EDTA treatment were evaluated. Functional validation included in vitro simulated gastrointestinal digestion and in vivo pharmacokinetic studies of miRNA-loaded EVs in murine models. Our results demonstrate that cheesemaking whey serves as a sustainable EV source with reduced casein contamination and comparable yields to milk. Both TFF and PEG co-precipitation effectively concentrate EVs from whey, offering viable UC alternatives for pharmaceutical scale-up, though additional purification steps are required for optimal purity. Acidification effectively removes protein contaminants from milk but shows minimal benefits for whey. Cow whey provided the highest EV yields among species evaluated. Functionally, EV-encapsulated miRNAs demonstrated superior gastrointestinal stability compared to free miRNAs and exhibited enhanced bioavailability in multiple target tissues including cardiac, splenic, and skeletal muscle following oral administration. These findings establish cheesemaking whey as a sustainable, pharmaceutical-grade EV source and validate scalable isolation methods suitable for therapeutic applications, providing essential groundwork for clinical translation of milk-derived EV-based drug delivery systems., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European Union NexGenerationEU/PRTR (TED2021–130962B-C21 and TED2021–130962B-C22) and ERDF A way of making Europe (PID2022–143100OB-I00 and RTI2018–098113-B-I00), by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409), and by the AGROALNEXT programme, supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1). MCLH is a recipient of a Ramon y Cajal Grant RYC2022–037626-I. CM-G is supported by a contract derived from European Union NexGenerationEU/PRTR (TED2021–130962B-C21). FV is partially supported by PRIN-2022 Prot. 2022NZNZH8. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of thermal culinary processing and gastrointestinal digestion on the stability, count, and biological effects of broccoli-derived extracellular vesicles

  • Mazarío-Gárgoles, Carmen
  • Del Saz-Lara, Andrea
  • Tomé-Carneiro, João
  • Martel, Rubén
  • Pastor Ballesteros, Laura
  • Burgos-Ramos, Emma
  • Briand, Olivier
  • López-Aceituno, José Luis
  • Bernabè, Giulia
  • Ávila-Gálvez, María Ángeles
  • Bautista, Liliana
  • Espín de Gea, Juan Carlos
  • López de Las Hazas, María-Carmen
  • Dávalos, Alberto
Plant-derived extracellular vesicles possess different intrinsic therapeutic activities that can potentially help prevent or treat human diseases. These EVs can be administered as such, or ingested daily in the diet. However, food EV sources are commonly subjected to cooking processes prior to consumption. Indeed, before any biological effect can be exerted, orally-administered EVs must overcome several technological, extracellular, and cellular barriers before reaching target tissues. To explore their capacity to exert biological effects, we evaluated the stability of broccoli-derived EVs under thermal culinary conditions and gastrointestinal digestion (GI), and their ability to cross the intestinal barrier. EVs were isolated from raw broccoli, broccoli sprouts and broccoli subjected to one of five thermal culinary treatments (frying, boiling, microwaving, scalding and steaming). Nanoparticle tracking analysis (particle size distribution, concentration, and z-potential), electron microscopy, and Western blot were used to characterize the EVs. They were run through a simulated in vitro GI tract and again characterized. Potential EV transport through the intestinal barrier was assessed using transwell-cultured differentiated Caco-2 cells, and their antiproliferative effects were evaluated in intestinal and hepatic cell lines. All five thermal culinary treatments lowered EV particle concentration, protein content, and cargo, as well as influencing EV structure. Around 10 % of the broccoli-derived EVs survived GI digestion. The RNA cargo of EVs can enter intestinal cells, but only a small amount of EVs cross the intestinal barrier. Thermal treatment also reduced EV antiproliferative effects. Broccoli-derived EVs are affected by thermal culinary processing and GI digestion, and cannot cross the intestinal barrier. However, even after thermal processing they apparently maintain some potential therapeutic effects., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European and ERDF A way of making Europe (PID2022-143100OB-I00), and by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409). Also funded by grant from Agence Nationale de la Recherche (# ANR-21-CE45-0017-03). MCLH is a recipient of a Ramon y Cajal Grant RYC2022–037626-I. CM-G and LB are supported by a contract derived from Union NexGenerationEU/PRTR (TED2021-130962B-C21). AS-L is supported by a predoctoral fellowship (N° 2021–01- PhD GRANT) from the International Olive Council. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hydroxytyrosol Enhances Plasma Extracellular Vesicle Secretion, Modulates Their miRNAs Cargo, and Reduces LDL Oxidation in Humans: Postprandial and 1-Week Effects

  • Del Saz-Lara, Andrea
  • López de Las Hazas, María-Carmen
  • Tomé-Carneiro, Joao
  • Ávila-Gálvez, Maria-Ángeles
  • Crespo, María Carmen
  • Mazarío-Gárgoles, Carmen
  • Chapado, Luis A
  • Daimiel, Lidia
  • Visioli, Francesco
  • Martín-Santiago, Victoria
  • Espín de Gea, Juan Carlos
  • Dávalos, Alberto
Hydroxytyrosol (HT) consumption is associated with healthy outcomes. Specifically, its ability to modulate microRNA (miRNA) expression has been described. However, whether HT influences the secretion of extracellular vesicles (EVs) and their transported miRNAs remains unknown. Here, following HT administration, we explored the potential changes in EV secretion and in their miRNA cargo during postprandial state and after 1 week of daily intake. Twelve healthy participants received, first, a single 25 mg dose of HT (postprandial study) and then 25 mg HT daily, for one week (sustained study). Plasma and circulating plasma-isolated EVs were analyzed for HT and derived metabolites using UPLC-qTOF-MS and miRNAs by RNA-seq. HT induced the secretion of EVs 1-h post-ingestion and a 1-week daily administration of HT increased fasting EVs and reduced circulating oxidized LDL levels. RNA-seq analysis identified 55 modulated miRNAs (30 upregulated and 25 downregulated) related to response to oxygen level and gland development, following 1-week HT supplementation. This pilot study sheds light on the effects of HT consumption on EV secretion and modulation of exosomal miRNAs in humans, which has been scarcely studied to date. Further research is warranted to elucidate the molecular mechanisms underlying the observed effects., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European and ERDF - “A way of making Europe” (PID2022-143100OB-I00 and PID2021-125899OB-I00), by the European Union NextGenerationEU/ PRTR (TED2021-130962B-C21 and TED2021-130962B-C22), by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409), and by the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain). M.C.L.H. is a recipient of a Ramon y Cajal Grant RYC2022-037626-I. C.M.-G. and L.B. are supported by a contract derived from Union NextGenerationEU/PRTR (TED2021-130962B-C21). A.S.-L. is supported by a predoctoral fellowship (N° 2021-01- PhD GRANT) from the International Olive Council. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain. F.V. is partially funded by PRIN-2022 Prot. 2022NZNZH8., Peer reviewed